# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4824242 | B | Inhibition of recombinant His-tagged Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli BL2(DE3) using TS2 as substrate by spectrophotometric assay | Leishmania infantum | 29 | assay format | Scientific Literature | ||
2. | ALA4824244 | B | Inhibition of recombinant His-FLAG-tagged Leishmania infantum TryR dimerization expressed in Escherichia coli BL2(DE3) assessed as reduction in TryR dimer using TS2 as substrate after 16 hrs by ELISA | Leishmania infantum | 27 | assay format | Scientific Literature | ||
3. | ALA4824246 | B | Inhibition of recombinant human GR oxidoreductase activity by DTNB-reagent based spectrophotometric method | Homo sapiens | 6 | single protein format | Scientific Literature | ||
4. | ALA4824258 | B | Inhibition of Trypanosoma brucei TryR oxidoreductase activity using TS2 as substrate by spectrophotometric assay | Trypanosoma brucei | 7 | single protein format | Scientific Literature | ||
5. | ALA4824259 | B | Inhibition of Trypanosoma congolense TryR oxidoreductase activity using TS2 as substrate by spectrophotometric assay | Trypanosoma congolense | 7 | assay format | Scientific Literature | ||
6. | ALA4824260 | A | Drug uptake in Leishmania infantum promastigotes at 25 uM after 1 hr by fluorescence microscopy analysis | Leishmania infantum | 1 | assay format | Scientific Literature | ||
7. | ALA4824261 | F | Antileishmanial activity against promastigote stage of Leishmania infantum MCAN/ES/89/IPZ229/1/89 infected in human HepG2 cells incubated for 24 hrs by propidium iodide staining based flow cytometry | Leishmania infantum | 23 | organism-based format | Scientific Literature | ||
8. | ALA4824262 | F | Antileishmanial activity against axenic amastigote stage of Leishmania infantum MCAN/ES/89/IPZ229/1/89 infected in human HepG2 cells incubated for 24 hrs by propidium iodide staining based flow cytometry | Leishmania infantum | 23 | organism-based format | Scientific Literature | ||
9. | ALA4824263 | A | Cytotoxicity against human HepG2 cells incubated for 24 hrs by crystal violet staining based assay | Homo sapiens | 23 | cell-based format | Scientific Literature | ||
10. | ALA4824264 | T | Selectivity index, ratio of EC50 for human HepG2 cells to EC50 for promastigote stage of Leishmania infantum MCAN/ES/89/IPZ229/1/89 infected in human HepG2 cells | 23 | cell-based format | Scientific Literature | |||
11. | ALA4824265 | T | Selectivity index, ratio of EC50 for human HepG2 cells to EC50 for axenic amastigote stage of Leishmania infantum MCAN/ES/89/IPZ229/1/89 infected in human HepG2 cells | 23 | cell-based format | Scientific Literature | |||
12. | ALA4824266 | F | Leishmanicidal activity against axenic amastigote stage of Leishmania infantum MCAN/ES/89/IPZ229/1/89 infected in human THP-1 macrophage cells assessed as reduction in intracellular amastigotes incubated for 24 hrs by propidium iodide staining based flow cytometry | Leishmania infantum | 13 | organism-based format | Scientific Literature | ||
13. | ALA4824267 | A | Cytotoxicity against human THP-1 cells by LDH assay | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
14. | ALA5250787 | P | Thermodynamic aqueous solubility of compound at 25 degreeC measured after 24 hrs by HPLC analysis | 8 | small-molecule physicochemical format | Scientific Literature | |||
15. | ALA5250799 | T | Selectivity index, ratio of CC50 for human HepG2 cells to EC50 for Leishmania infantum MCAN/ES/89/IPZ229/1/89 axenic amastigotes | 18 | assay format | Scientific Literature | |||
16. | ALA5250800 | F | Antileishmanial activity against GFP-expressing Leishmania infantum intracellular amastigotes infected in human THP-1 derived macrophage cells assessed as reduction in parasite viability measured for 72 hrs by resazurin/alamar blue fluorometric assay | Leishmania infantum | 14 | organism-based format | Scientific Literature | ||
17. | ALA5250801 | T | Cytotoxicity against human HepG2 cells assessed as reduction in cell proliferation measured after 72 hrs by crystal violet staining based analysis | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
18. | ALA5250802 | T | Selectivity index, ratio of CC50 for human HepG2 cells to EC50 for GFP-expressing Leishmania infantum intracellular amastigotes infected in human THP-1 derived macrophage cells | 14 | cell-based format | Scientific Literature |